IRIS
CODULLO, VERONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.905
AS - Asia 1.349
EU - Europa 1.227
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 73
OC - Oceania 5
Totale 4.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.847
CN - Cina 524
SG - Singapore 344
IE - Irlanda 253
DE - Germania 230
BR - Brasile 163
RU - Federazione Russa 159
VN - Vietnam 145
HK - Hong Kong 143
FI - Finlandia 141
IT - Italia 97
FR - Francia 70
AT - Austria 60
BD - Bangladesh 55
GB - Regno Unito 54
IN - India 46
ZA - Sudafrica 44
UA - Ucraina 41
CA - Canada 34
SE - Svezia 34
AR - Argentina 21
JP - Giappone 21
NL - Olanda 16
IQ - Iraq 14
PL - Polonia 14
CO - Colombia 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
MA - Marocco 10
ES - Italia 9
SA - Arabia Saudita 9
BE - Belgio 8
MX - Messico 8
VE - Venezuela 8
MY - Malesia 7
UZ - Uzbekistan 7
ID - Indonesia 6
BO - Bolivia 5
KE - Kenya 5
CL - Cile 4
JM - Giamaica 4
MK - Macedonia 4
PK - Pakistan 4
TN - Tunisia 4
TR - Turchia 4
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
Totale 4.790
Salva come PNG Salva come JPEG
Città #
Dublin 248
Chandler 227
San Jose 227
Singapore 193
Ashburn 186
Dallas 155
Hong Kong 141
Munich 141
Beijing 121
Helsinki 85
Nanjing 84
Jacksonville 71
Council Bluffs 69
Los Angeles 57
Boardman 53
Vienna 53
New York 48
Ho Chi Minh City 47
Lauterbourg 44
Johannesburg 38
Princeton 36
Lawrence 35
Nanchang 34
Shanghai 32
Hanoi 28
Medford 28
Shenyang 27
São Paulo 27
Moscow 26
Buffalo 24
Wilmington 24
Milan 22
Orem 22
Turku 22
Pavia 21
Tokyo 20
Santa Clara 18
Seattle 18
Jiaxing 17
Changsha 15
Hebei 14
Hangzhou 13
London 13
Redondo Beach 13
Ann Arbor 12
Chennai 12
Columbus 12
Montreal 12
Warsaw 12
Amsterdam 10
Da Nang 10
Poplar 10
Brno 9
Chicago 9
Denver 9
Haiphong 9
Houston 9
San Francisco 9
The Dalles 9
Toronto 9
Atlanta 8
Brooklyn 8
Brussels 8
Frankfurt am Main 8
Rio de Janeiro 8
Tianjin 8
Woodbridge 8
Boston 7
Falkenstein 7
Norwalk 7
Phoenix 7
Pune 7
Stockholm 7
Baghdad 6
Dhaka 6
Fairfield 6
Manchester 6
Tashkent 6
Guangzhou 5
Jyväskylä 5
Mumbai 5
Nuremberg 5
Zhengzhou 5
Biên Hòa 4
Düsseldorf 4
Guayaquil 4
La Paz 4
Medellín 4
Mexico City 4
Naples 4
Paris 4
Berlin 3
Brasília 3
Bến Tre 3
Calgary 3
Elk Grove Village 3
Falls Church 3
Hải Dương 3
Juneau 3
Kuala Lumpur 3
Totale 3.211
Salva come PNG Salva come JPEG
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 268
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 158
B cells in rheumatoid arthritis. 155
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 155
Antinuclear antibodies in systemic sclerosis 140
Disease-related malnutrition in systemic sclerosis: Evidences and implications 140
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 135
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 133
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 131
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 128
B cells in rheumatoid arthritis. 123
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 121
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 118
Fetal programming and systemic sclerosis 111
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 110
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 108
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 107
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 105
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 104
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 101
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 99
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 95
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 95
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 94
A 28-Year-Old Man with Stridor and Dyspnea 94
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 92
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 92
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 91
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 90
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 90
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 90
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 90
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 89
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 88
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 88
Pathophysiology of systemic sclerosis 84
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 83
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 82
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 82
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 78
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 75
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 74
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 72
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 70
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 64
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 43
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 34
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts 8
Totale 4.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022172 0 1 2 4 0 8 1 6 14 4 26 106
2022/2023688 71 66 12 62 58 68 1 42 273 5 22 8
2023/2024297 34 58 9 15 13 67 13 27 0 22 8 31
2024/2025975 21 45 9 22 15 90 93 81 242 41 102 214
2025/20262.057 147 103 221 227 225 114 329 106 201 140 93 151
2026/2027100 40 60 0 0 0 0 0 0 0 0 0 0
Totale 4.877